| 2-SCD | 2-S-cysteinyldopa |
| 4-AHP | 4-Amino-3-hydroxyphenylalanine |
| 5-SCD | 5-S-cysteinyldopa |
| ACTH | Adrenocorticotropic hormone |
| ADAM17 | ADAM metallopeptidase domain 17 |
| ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif 20 |
| AKT1 | AKT Serine/Threonine Kinase 1 |
| ASIP | Agouti signaling protein |
| ATRN | Attractin |
| BCC | Basal cell carcinoma |
| BED | Biologically efficient dose |
| bFGF | Basic FGF |
| BNC2 | Basonuclin 2 |
| CIE | Commission Internationale de l’Eclairage |
| CPD | Cyclobutane pyrimidine dimer |
| DCT | DOPA chrome tautomerase |
| DDB1 | Damage specific DNA binding protein 1 |
| DHI | 5,6-Dihydroxyindole |
| DHICA | 5,6-Dihydroxyindole-2-carboxylic acid |
| DNA | Deoxyribonucleic acid |
| DNA-PF | DNA-Protection factor |
| DOPA | l-3,4-dihydroxyphenyilalanine |
| DRS | Diffuse reflectance spectroscopy |
| DT | Delayed tanning |
| DTNBP1 | Dystrobrevin binding protein 1 |
| ECM | Extracellular matrix |
| EDA | Ectodysplasin A |
| EDN3 | Endothelin 3 |
| EGFR | Epidermal growth factor receptor |
| EI | Erythema index |
| FGFR3 | Fibroblast growth factor receptor 3 |
| FOXN1 | Forkhead box N1 |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| GWAS | Genome-wide association study |
| HERC2 | HECT And RLD domain containing E3 ubiquitin protein ligase 2 |
| HGF | Hepatocyte growth factor |
| HLA-C | Major histocompatibility complex, class I, C |
| HPLC | High-Performance liquid chromatography |
| IL1α | Interleukin 1 alpha |
| IPD | Immediate pigment darkening |
| IR | Infrared radiation |
| IRF4 | Interferon regulatory Factor 4 |
| ITA | Individual typology angle |
| KITLG | KIT ligand |
| LYST | Lysosomal trafficking regulator |
| MATP | Solute carrier family 45, member 2 |
| MC1R | Melanocortin-1 receptor |
| MED | Minimal erythemal dose |
| MFSD12 | Major facilitator superfamily domain containing 12 |
| MI | Melanin index |
| MITF | Microphthalmia-associated transcription factor |
| MM | Malignant melanoma |
| MYO5A | Myosin VA |
| OCA1 | Oculocutaneous albinism type 1 |
| OCA2 | Oculocutaneous albinism type 2 |
| OPN3 | Opsin 3 |
| PIH | Postinflammatory hyperpigmentation |
| PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PKA | Protein kinase A |
| POMC | Proopiomelanocortin |
| PPD | Persistent pigment darkening |
| PTCA | Pyrrole-2,3,5-tricarboxylic acid |
| ROS | Reactive oxygen species |
| SBC | Sunburn cell |
| SCC | Squamous cell carcinoma |
| SK | Seborrheic Keratosis |
| SLC24A5 | Solute carrier family 24, member 5 |
| SLC45A2 | Solute carrier family 45, member 2 |
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 2 |
| SNP | Single nucleotide polymorphism |
| SNX13 | Sorting nexin 13 |
| SPF | Sun protection factor |
| SPT | Skin phototype |
| SSR | Solar simulated radiation |
| TERT | Telomerase reverse transcriptase |
| TMEM38 | Transmembrane protein 38 |
| TPCN2 | Two pore segment channel 2 |
| TRP1 | Tyrosinase-related protein 1 |
| TRP2 | Tyrosinase-related protein 2 |
| TTCA | Thiazole-2,4,5-tricarboxylic acid |
| TYR | Tyrosinase |
| UVA | Ultraviolet radiation A |
| UVB | Ultraviolet radiation B |
| UVR | Ultraviolet radiation |
| VLDLR | Very low density lipoprotein receptor |
| αMSH | Alpha-Melanocyte-stimulating hormone |